Arbiter's AI Orchestration Platform Is Already Live With 1,000 Clinicians

The six-month-old startup, led by healthcare veterans, landed a $52M seed at a $400M valuation to automate referrals and site-of-care decisions.

About Arbiter

Published

In a healthcare system where a patient’s journey is often a series of disconnected handoffs, the promise of AI is not just to predict, but to connect. Arbiter, a New York-based startup that emerged from stealth in November 2025, is betting that the most valuable automation lies in the mundane, high-friction workflows of care coordination. The company’s platform, which unifies clinical, financial, and policy data, aims to act as a central nervous system for payers and providers, automating tasks like referrals and scheduling while optimizing where a patient receives care. It is an ambitious attempt to address fragmentation not with another point solution, but with an orchestration layer that sits across the existing infrastructure [PR Newswire, Nov 2025].

The Record-Action-Alignment Wedge

Arbiter’s approach is encapsulated in its ‘Record-Action-Alignment’ model. The first step involves creating a longitudinal patient record by integrating data from electronic health records, claims, and payer policies. The platform then uses this unified view to trigger automated actions, such as initiating a specialist referral or booking an appointment. The final component, alignment, is about ensuring the suggested next step works for the payer’s cost parameters, the provider’s availability, and the patient’s preferences [HIT Consultant, Nov 2025]. Its first application, launched in partnership with an unnamed national payer and major provider networks, focuses on site-of-care optimization. When a patient needs an MRI or a procedure, the system can recommend the most appropriate facility based on a real-time analysis of cost, quality scores, and appointment slots, then handle the authorization and scheduling outreach automatically [PR Newswire, Nov 2025].

A Team Built for Healthcare’s Complexities

The company’s rapid traction,it reports being live with over 1,000 clinicians,is underpinned by a team assembled to navigate healthcare’s regulatory and operational maze [Business Insider, Nov 2025]. CEO Michelle Carnahan previously held leadership roles at Eli Lilly, Cigna, UnitedHealth, Kaiser Permanente, and VillageMD, giving her a rare cross-sectional view of pharma, payer, and provider incentives [HIT Consultant, Nov 2025]. The broader team includes executives from those same incumbent organizations, as well as technologists from Meta, Apple, Google, and Amazon [Business Insider, Nov 2025]. This blend is designed to marry deep domain expertise with modern software development velocity. A key accelerant was the acquisition of SecondWave Delivery Systems, which brought both a data unification layer and an existing customer base into Arbiter’s fold [Business Insider, Nov 2025].

The company’s leadership and initial focus areas are summarized below.

Role / Focus Key Detail Source
CEO Background Michelle Carnahan (ex-Eli Lilly, Cigna, UnitedHealth, Kaiser, VillageMD) [HIT Consultant, Nov 2025]
Technical Talent Team includes engineers from Meta, Apple, Google, Amazon [Business Insider, Nov 2025]
Initial Product Site-of-care optimization for referrals [PR Newswire, Nov 2025]
Acquisition SecondWave Delivery Systems (data layer & customers) [Business Insider, Nov 2025]

The $400M Valuation Question

Arbiter’s $52 million seed round, led by family offices TriEdge Investments and MFO Ventures with participation from WindRose Health Investors, arrived with a reported post-money valuation of $400 million [Business Insider, Nov 2025]. For a company founded only about six months prior, that figure immediately raises the stakes and the scrutiny. The funding environment suggests investors are placing a high premium on teams that can credibly bridge healthcare and technology, but it also sets a high bar for commercial execution. The absence of traditional venture capital firms in the cap table, while not unusual for highly regulated sectors, may reflect a specific investor thesis around navigating payer and provider sales cycles, which are famously long and complex. The company’s current hiring push for senior AI engineers and EMR integration specialists, as seen in its job postings, signals where it plans to invest heavily to build defensibility [AshbyHQ, 2026]. The risks here are not about the problem,care coordination is a massive, costly inefficiency,but about execution velocity and proof of economic impact.

  • Integration depth. The platform’s value hinges on deep, reliable connections to dozens of EHR and payer systems, a technically and legally arduous task that has sunk many prior attempts.
  • Economic proof. While automating a referral saves administrative cost, the real ROI for a payer comes from consistently steering patients to higher-value care settings. Demonstrating sustained savings at scale will be the ultimate test.
  • Competitive landscape. While no direct competitors were named in sources, Arbiter operates in a crowded arena of revenue cycle management and care navigation tools. Its differentiation rests on the breadth of its ‘Record-Action-Alignment’ model versus more niche point solutions.

The company is initially targeting patients who require scheduled procedures like imaging scans or outpatient surgeries, a population that often faces delays and confusion during the referral process. For these individuals, the standard of care today is a phone-based game of telephone: a primary care doctor’s office faxes a referral, an insurance company reviews it for authorization, and the patient is left to call around to facilities to find one that is in-network and has availability. It is a process measured in days or weeks, burdened by manual work, and prone to errors that lead to patient frustration and higher costs. Arbiter’s bet is that by making this flow instantaneous and data-driven, it can improve both the economics of care and the experience of receiving it.

Sources

  1. [PR Newswire, Nov 2025] Arbiter Emerges from Stealth with $52M to Build the AI System that Connects Healthcare | https://www.prnewswire.com/news-releases/arbiter-emerges-from-stealth-with-52m-to-build-the-ai-system-that-connects-healthcare-302620237.html
  2. [Business Insider, Nov 2025] Health Startup Arbiter Grabs $52 Million at $400 Million Valuation | https://www.businessinsider.com/health-startup-arbiter-grabs-52-million-at-400-million-valuation-2025-11
  3. [HIT Consultant, Nov 2025] Arbiter Emerges from Stealth with $52M Funding to End Healthcare Fragmentation with AI | https://hitconsultant.net/2025/11/19/arbiter-emerges-from-stealth-with-52m-funding-to-end-healthcare-fragmentation-with-ai/
  4. [AshbyHQ, 2026] Arbiter AI Jobs | https://jobs.ashbyhq.com/arbiter-ai

Read on Startuply.vc